Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancer.
Bennouna J, Deslandres M, Senellart H, de Labareyre C, Ruiz-Soto R, Wixon C, Botbyl J, Suttle AB, Delord JP. Bennouna J, et al. Among authors: delord jp. Invest New Drugs. 2015 Feb;33(1):138-47. doi: 10.1007/s10637-014-0142-1. Epub 2014 Sep 24. Invest New Drugs. 2015. PMID: 25248752 Clinical Trial.
Toxicity patterns of cytotoxic drugs.
Chatelut E, Delord JP, Canal P. Chatelut E, et al. Among authors: delord jp. Invest New Drugs. 2003 May;21(2):141-8. doi: 10.1023/a:1023565227808. Invest New Drugs. 2003. PMID: 12889735 Review.
Vinflunine: a novel antitubulin agent in solid malignancies.
Bennouna J, Campone M, Delord JP, Pinel MC. Bennouna J, et al. Among authors: delord jp. Expert Opin Investig Drugs. 2005 Oct;14(10):1259-67. doi: 10.1517/13543784.14.10.1259. Expert Opin Investig Drugs. 2005. PMID: 16185168 Review.
Vinflunine: a new microtubule inhibitor agent.
Bennouna J, Delord JP, Campone M, Nguyen L. Bennouna J, et al. Among authors: delord jp. Clin Cancer Res. 2008 Mar 15;14(6):1625-32. doi: 10.1158/1078-0432.CCR-07-2219. Clin Cancer Res. 2008. PMID: 18347163 Review.
Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study.
Bennouna J, Borg C, Delord JP, Husseini F, Trillet-Lenoir V, Faroux R, François E, Ychou M, Goldwasser F, Bouché O, Senellart H, Kraemer S, Douillard JY. Bennouna J, et al. Among authors: delord jp. Clin Colorectal Cancer. 2012 Mar;11(1):38-44. doi: 10.1016/j.clcc.2011.05.002. Epub 2011 Jul 29. Clin Colorectal Cancer. 2012. PMID: 21803002 Clinical Trial.
242 results